Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Expert Opinion on Investigational Drugs
|
August 15, 2009
New generation azole antifungals in clinical investigation
Corrado Girmenia
F1000Research
|
August 3, 2019
New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies
Corrado Girmenia
Current Opinion in Oncology
|
July 23, 2003
New antifungal drugs and new clinical trials: interpreting results may be difficult
Corrado Girmenia, Pietro Martino
Seminars in Respiratory and Critical Care Medicine
|
November 4, 2005
Pulmonary infections complicating hematological disorders
Corrado Girmenia, Pietro Martino
Expert Opinion on Drug Safety
|
December 23, 2016
An update on the safety and interactions of antifungal drugs in stem cell transplant recipients
Corrado Girmenia, Anna Paola Iori
Expert Opinion on Drug Safety
|
August 24, 2012
Safety and interactions of new antifungals in stem cell transplant recipients
Corrado Girmenia, Anna Paola Iori
Diagnostic Microbiology and Infectious Disease
|
July 18, 2003
Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections
Corrado Girmenia, Mario Venditti, Pietro Martino
Current Opinion in Hematology
|
October 9, 2014
Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation
Corrado Girmenia, Antonietta Ferretti, Walter Barberi
Expert Review of Hematology
|
April 22, 2016
The risk of infections in patients with myelodysplastic syndromes in 2016
Morena Caira, Roberto Latagliata, Corrado Girmenia
Mediterranean Journal of Hematology and Infectious Diseases
|
July 22, 2016
Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries
Corrado Girmenia, Alessandra Serrao, Martina Canichella
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Expert Opinion on Investigational Drugs
|
August 15, 2009
New generation azole antifungals in clinical investigation
Corrado Girmenia
F1000Research
|
August 3, 2019
New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies
Corrado Girmenia
Current Opinion in Oncology
|
July 23, 2003
New antifungal drugs and new clinical trials: interpreting results may be difficult
Corrado Girmenia, Pietro Martino
Seminars in Respiratory and Critical Care Medicine
|
November 4, 2005
Pulmonary infections complicating hematological disorders
Corrado Girmenia, Pietro Martino
Expert Opinion on Drug Safety
|
December 23, 2016
An update on the safety and interactions of antifungal drugs in stem cell transplant recipients
Corrado Girmenia, Anna Paola Iori
Expert Opinion on Drug Safety
|
August 24, 2012
Safety and interactions of new antifungals in stem cell transplant recipients
Corrado Girmenia, Anna Paola Iori
Diagnostic Microbiology and Infectious Disease
|
July 18, 2003
Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections
Corrado Girmenia, Mario Venditti, Pietro Martino
Current Opinion in Hematology
|
October 9, 2014
Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation
Corrado Girmenia, Antonietta Ferretti, Walter Barberi
Expert Review of Hematology
|
April 22, 2016
The risk of infections in patients with myelodysplastic syndromes in 2016
Morena Caira, Roberto Latagliata, Corrado Girmenia
Mediterranean Journal of Hematology and Infectious Diseases
|
July 22, 2016
Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries
Corrado Girmenia, Alessandra Serrao, Martina Canichella
Page
of 9